Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05744687
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2023-02-16
Brief Title:
Phase IIIII Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Organization Data
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Class:
INDUSTRY
Study ID:
SPH4336-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None